 CASE STUDY
Swift Identification of Lab Partner Expands Services into Mainland China
Situation
The Chinese government body will not allow whole blood specimens to be shipped outside of country boundaries. ACM Global Central Lab needed to develop an alternative solution to address the growing demand for clinical trials in emerging markets such as
Objective
To find a suitable partner to provide central lab services in mainland China.
Solution
ACM evaluated several prospective laboratory partners in mainland China. The final selection was with an English-speaking, CAP-certified lab in Beijing.
Benefit
By setting up a team of highly experienced clinical trial professionals, ACM now offers its clients global central laboratory services in support of its needs in China.
|  
|
 |
 |
 |
